A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries

NCT01101347 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-11-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate safety and performance of the Surpass Aneurysm-Embolization System.

Conditions

  • Aneurysm

Interventions

DEVICE

Aneurysm-Embolization System

Sponsors & Collaborators

  • Surpass Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Vipul Gupta, MD · Medanta, Medcity

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101347 on ClinicalTrials.gov